Characterization of specificity of incorporation of 75Seselenomethionine into human apoproteins following in-vivo injection of the radioactive amino acid precursor is reported. Apoprotein fractionation was attained by serial ultracentrifugation, anhydrous partial delipidization, decyl sulfate solubilization with Sephadex G-150 gel filtration into polypeptide fractions, Sf-I, and Sf-II, for VLDL, and LDL subfractions. Similarity of the Sf-I fractions isolated from VLDL, LDL1 and LDL2 was defined by gel exclusion volume, disk-gel electrophoresis, immunodiffusion, and amino acid composition. Enrichment of the Sf-I fractions with75Se-SM in VLDL and LDL subfractions was observed, suggesting a possible use for this isotopic method for the investigation of apoprotein metabolism.
Skip Nav Destination
Article navigation
Original contribution|
January 01 1976
Incorporation of 75Se-Selenomethionine into Human Apoproteins: I. Characterization of Specificity in Very-low-density and Low-density Lipoproteins
R Philip Eaton, MD
R Philip Eaton, MD
Department of Medicine, University of New Mexico School of Medicine
Albuquerque, New Mexico 87131
Search for other works by this author on:
Citation
R Philip Eaton; Incorporation of 75Se-Selenomethionine into Human Apoproteins: I. Characterization of Specificity in Very-low-density and Low-density Lipoproteins. Diabetes 1 January 1976; 25 (1): 32–43. https://doi.org/10.2337/diab.25.1.32
Download citation file:
21
Views